BIOTRICITY INC. (BTCY): Nasdaq/NYSE listing notice — Biotricity receives Nasdaq deficiency letter for MVLS below $35M minimum

BIOTRICITY INC.

On Aug 1, 2023, Biotricity received Nasdaq notice: MVLS < $35M for 30 consecutive business days.
No immediate delisting effect; company has 180 days (until Jan 29, 2024) to regain compliance.
To regain compliance, MVLS must close at ≥ $35M for a minimum of 10 consecutive business days.
Company intends to monitor market value and may consider available options.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BIOTRICITY INC. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

August 1, 2023, Biotricity Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the $35 million minimum requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). The notification received has no immediate effect on the Company’s Nasdaq listing. In accordance with Nasdaq rules, the Company

View on SEC.gov

Browse all listing & compliance notices →

BIOTRICITY INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-026879

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.